ÁñÁ«ÊÓƵ

This cohort study assesses the association of diltiazem with risk of serious bleeding compared with metoprolol in older adults with atrial fibrillation receiving apixaban or rivaroxaban.

This cohort study of US veterans hospitalized with COVID-19 with genetic information and with African ancestry through the VA Million Veteran Program to evaluates the association of APOL1 variations with.acute kidney injury

This cohort study assesses major ischemic and hemorrhagic outcomes in Medicare beneficiaries with atrial fibrillation who were treated with rivaroxaban compared with apixaban.

This cohort study tests the associations between PCSK9 genetic variants, a PCSK9 genetic risk score, or genetically estimated PCSK9 expression levels and the risk of sepsis among patients admitted to a hospital with infection.

This cohort study of medical records assesses whether low-density lipoprotein cholesterol (LDL-C) levels are associated with an increased risk of sepsis among patients admitted to the hospital with infection.

This pharmacoepidemiology study examines the association between oral anticoagulants (warfarin, apixaban, dabigatran, and rivaroxaban), cotherapy with proton pump inhibitors (PPIs), and upper gastrointestinal (UGI) tract bleeding in Medicare beneficiaries.

This retrospective study compared risk of death among Medicaid patients in Tennessee initiating long-acting opioid therapy for chronic noncancer pain with patients taking anticonvulsants or cyclic antidepressants.

This retrospective cohort study determines that the increased risk of death associated with methadone use outside the hospital supports recommendations that it should not be a drug of first choice for treatment of noncancer pain.